We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Featured Products

 
 

Product News

 
Horizon Licenses Use of GS Knockout CHO K1 Cell Line to NGM Bio

Product News

Horizon has announced that it will license its gene-edited Glutamine Synthetase (GS) knockout Chinese Hamster Ovary (CHO) K1 cell line to NGM Biopharmaceuticals.

READ MORE

International Freezer Challenge 2020: Optimizing Your Cold Storage Practices?

Product News

The International Institute for Sustainable Laboratories (I2SL) and MyGreenLab have partnered again to reward the best concept to improve cold storage regarding sustainability: The Freezer Challenge 2020.

READ MORE

Bioprocessing Summit Europe 2020: New Analytical and Formulation Sessions

Product News

Cambridge Healthtech Institute has announced the return of Bioprocessing Summit Europe, with the addition of approximately 30 new sessions on Analytical and Formulation topics.

READ MORE

ProBioGen and Lava Therapeutics Sign Development and Manufacturing Agreement for Novel Bispecific Molecule

Product News

ProBioGen and Lava Therapeutics have announced the closing of a cell line development and manufacturing agreement for Lava’s novel bispecific antibody lead candidate.

READ MORE

Horizon Discovery to Provide Access to Novel Base Editing Technology

Product News

Horizon Discovery has announced that it will provide access to a novel base editing technology licensed from Rutgers for exclusive use in therapeutic, diagnostic and services applications.

READ MORE

Horizon Discovery and Mammoth Biosciences Collaborate To Improve Biotherapeutic Production

Product News

Horizon Discovery has signed a collaboration and license agreement with Mammoth Biosciences, to access Mammoth’s novel CRISPR platform and thereby facilitate delivery of a new generation of genetically engineered CHO cells for the production of biotherapeutics.

READ MORE

Enterprise Publish Novel Therapeutic Approach for Cystic Fibrosis Patients

Product News

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company aimed towards the discovery and development of novel therapies to improve the lives of patients suffering with respiratory disease, has announced the publication of its first peer-reviewed paper.

READ MORE

Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture

Product News

Avacta and Daewoong Pharmaceutical have announced a collaboration to develop the next generation of cell and gene therapies incorporating Affimer proteins to enhance the immune-modulatory effects.

READ MORE

VivopureX™ Recombinant Antibodies for In Vivo Research

Product News

Absolute Antibody has announced the launch of its VivopureX™ recombinant mouse antibodies for in vivo research in mouse models.

READ MORE

Expedeon Approves Future Focus on DNA Manufacturing For Gene Therapy

Product News

Expedeon shareholders have approved the sale of its proteomics and immunology business, as well as the proposed name change to 4basebio AG, reflecting the Company’s future focus on DNA manufacturing for gene therapy and gene vaccines.

READ MORE